---

Mucormycosis during the COVID-19 pandemicOur takeaways

---

Original Article

Author Details : Shruti Jha, Mani Mala, Rakesh Kumar Singh*

Volume : 7, Issue : 2, Year : 2024

Article Page : 31-34

https://doi.org/10.18231/j.ijoas.2024.009

Suggest article by email

Get Permission

---

Abstract

Background: is a rare, opportunistic fungal infection that affects immune-compromised hosts. When involving the PNS, it can be Rhino-orbital or Rhinocerebral and may rapidly prove fatal.
Methods: We present a retrospective case series analysis of 48 patients from the COVID-19 pandemic, our management of them, and our takeaways.
Result: Out of 48, 12 had a previous history of oxygen therapy, 32 had tested positive for COVID-19 recently,8 had a history of ICU admission, and the most common occupations affected were homemakers and housewives. Grade 2 and 3 of rhino-orbital cerebral (ROCM)were most commonly found, and 28 developed type 2 diabetes before and after ROCM and 4 in the aftermath of the disease.
Conclusion: A high degree of suspicion should be maintained in all patients with nasal, orbital, or neuro complaints with a previous history of COVID-19 infection and with or without co-morbid conditions.

Keywords: Mucormycosis, Fungal infection, Diabetes mellitus, COVID-19

How to cite : Jha S, Mala M, Singh R K, Mucormycosis during the COVID-19 pandemicOur takeaways. J Otorhinolaryngol Allied Sci 2024;7(2):31-34

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.